Neuropeptide Y

DB11788ApprovedInvestigationalWithdrawnProtein Based Therapies

Neuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus.

Also known as
NPY

Resolves to

Compound
UNIIBY7U39XXK0CAS82785-45-3
Clinical / RWD
RxNorm7366
Targets
P25929NPY1RP49146NPY2R

What you can answer from here — as of September 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Neuropeptide Y, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In